CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.

But this was plausibly an overestimate. The comparison of negotiated and net prices cannot strictly be interpreted as savings, because for drugs selected for negotiation, manufacturers won’t be ...

Other countries will be used as examples with which to compare Colombia ... industry in the price regulation. Once the new policy is approved the drugs under a pharma monopoly are going to ...

The board’s annual report for 2023 shows that its budget and staff are 56 per cent and 18 per cent, respectively, above their ...

President Trump will still seek a win over the previous administration’s efforts to lower drug prices, Kelly Griffin, director of the health policy and intelligence institute at PwC U.S., said ...

Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.

Those net prices are not public, so it’s hard to precisely compare the negotiated prices on the first 10 drugs, which take effect in 2026, to what Medicare paid previously. For this second round ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

President Donald Trump likely won't do away with a process that allows Medicare to negotiate drug prices with manufacturers, even as he erases Joe Biden's other policy accomplishments. But Trump ...

Piper Sandler analyst Yasmeen Rahimi initiated coverage with a Buy rating on Bright Minds Biosciences (DRUG – Research Report) today and set a ...